Search research articles
Contact Us
Filters
Showing results (21-30 of 186) with videos related to
Page
of 19
Sort By:
Breast Cancer Research and Treatment
|
August 25, 2011
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels
Liying Zhang, Lishi Chen, Ruben Bacares, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Exploring the genetic and epigenetic underpinnings of early-onset cancers: Variant prioritization for long read whole genome sequencing from family cancer pedigrees
Melissa Kramer, Sara Goodwin, Robert Wappel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 5, 2021
Tumor Mutational Burden and Mismatch Repair Deficiency Discordance as a Mechanism of Immunotherapy Resistance
Agata A Bielska, Walid K Chatila, Henry Walch, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 12, 2022
An updated counseling framework for moderate-penetrance colorectal cancer susceptibility genes
Kelsey E Breen, Bryson W Katona, Amanda Catchings, et al.
Breast Cancer Research and Treatment
|
March 12, 2010
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families
Zsofia K Stadler, Emmanuel Saloustros, Nichole A L Hansen, et al.
Hematology/Oncology Clinics of North America
|
September 7, 2010
Genome-wide association studies of cancer predisposition
Zsofia K Stadler, Joseph Vijai, Peter Thom, et al.
Clinical Colorectal Cancer
|
March 20, 2012
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized
Emily Steinhagen, José G Guillem, Gerard Chang, et al.
Journal for Immunotherapy of Cancer
|
November 22, 2018
Acquired resistance to immunotherapy in MMR-D pancreatic cancer
Zishuo Ian Hu, Matthew D Hellmann, Jedd D Wolchok, et al.
Expert Review of Gastroenterology & Hepatology
|
February 17, 2016
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches
Ibrahim H Sahin, Maeve A Lowery, Zsofia K Stadler, et al.
European Journal of Human Genetics : EJHG
|
February 23, 2021
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant
Zarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 186) with videos related to
Sort By:
Page
of 19
Breast Cancer Research and Treatment
|
August 25, 2011
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels
Liying Zhang, Lishi Chen, Ruben Bacares, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Exploring the genetic and epigenetic underpinnings of early-onset cancers: Variant prioritization for long read whole genome sequencing from family cancer pedigrees
Melissa Kramer, Sara Goodwin, Robert Wappel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 5, 2021
Tumor Mutational Burden and Mismatch Repair Deficiency Discordance as a Mechanism of Immunotherapy Resistance
Agata A Bielska, Walid K Chatila, Henry Walch, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 12, 2022
An updated counseling framework for moderate-penetrance colorectal cancer susceptibility genes
Kelsey E Breen, Bryson W Katona, Amanda Catchings, et al.
Breast Cancer Research and Treatment
|
March 12, 2010
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families
Zsofia K Stadler, Emmanuel Saloustros, Nichole A L Hansen, et al.
Hematology/Oncology Clinics of North America
|
September 7, 2010
Genome-wide association studies of cancer predisposition
Zsofia K Stadler, Joseph Vijai, Peter Thom, et al.
Clinical Colorectal Cancer
|
March 20, 2012
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized
Emily Steinhagen, José G Guillem, Gerard Chang, et al.
Journal for Immunotherapy of Cancer
|
November 22, 2018
Acquired resistance to immunotherapy in MMR-D pancreatic cancer
Zishuo Ian Hu, Matthew D Hellmann, Jedd D Wolchok, et al.
Expert Review of Gastroenterology & Hepatology
|
February 17, 2016
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches
Ibrahim H Sahin, Maeve A Lowery, Zsofia K Stadler, et al.
European Journal of Human Genetics : EJHG
|
February 23, 2021
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant
Zarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
Page
of 19